200 related articles for article (PubMed ID: 9782018)
21. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis.
Stewart AH; Eyers PS; Earnshaw JJ
J Vasc Surg; 2007 Jul; 46(1):148-55. PubMed ID: 17606135
[TBL] [Abstract][Full Text] [Related]
22. Does the timing of reoperation influence the risk of graft infection?
Kolakowski S; Dougherty MJ; Calligaro KD
J Vasc Surg; 2007 Jan; 45(1):60-4. PubMed ID: 17123767
[TBL] [Abstract][Full Text] [Related]
23. Cryopreserved arterial allografts in the treatment of prosthetic graft infections.
Gabriel M; Pukacki F; Dzieciuchowicz Ł; Oszkinis G; Checiński P
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):590-6. PubMed ID: 15121108
[TBL] [Abstract][Full Text] [Related]
24. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin.
Avramovic J; Fletcher JP
J Cardiovasc Surg (Torino); 1992; 33(1):70-4. PubMed ID: 1531988
[TBL] [Abstract][Full Text] [Related]
25. Prosthetic vascular graft infection: a risk factor analysis using a case-control study.
Antonios VS; Noel AA; Steckelberg JM; Wilson WR; Mandrekar JN; Harmsen WS; Baddour LM
J Infect; 2006 Jul; 53(1):49-55. PubMed ID: 16310254
[TBL] [Abstract][Full Text] [Related]
26. Interaction between vascular prostheses and rifampicin in the prevention of the grafts infection. An experimental study.
Freyrie A; Curti T; Rodio M; Masetti L; Bignozzi L; Sanguinetti V; Joechler M; D'Addato M
Int Angiol; 1992; 11(2):113-6. PubMed ID: 1402214
[TBL] [Abstract][Full Text] [Related]
27. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
29. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge.
Vicaretti M; Hawthorne WJ; Ao PY; Fletcher JP
Cardiovasc Surg; 1998 Jun; 6(3):268-73. PubMed ID: 9705099
[TBL] [Abstract][Full Text] [Related]
30. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
Yasim A; Gul M; Ciralik H; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
[TBL] [Abstract][Full Text] [Related]
31. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
32. Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial.
Eiberg JP; Røder O; Stahl-Madsen M; Eldrup N; Qvarfordt P; Laursen A; Greve M; Flörenes T; Nielsen OM; Seidelin C; Vestergaard-Andersen T; Schroeder TV
Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):431-8. PubMed ID: 16807001
[TBL] [Abstract][Full Text] [Related]
33. Collagen- versus gelatine-coated Dacron versus stretch PTFE bifurcation grafts for aortoiliac occlusive disease: long-term results of a prospective, randomized multicenter trial.
Prager MR; Hoblaj T; Nanobashvili J; Sporn E; Polterauer P; Wagner O; Böhmig HJ; Teufelsbauer H; Ploner M; Huk I
Surgery; 2003 Jul; 134(1):80-5. PubMed ID: 12874586
[TBL] [Abstract][Full Text] [Related]
34. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
[TBL] [Abstract][Full Text] [Related]
35. Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics.
Javerliat I; Goëau-Brissonnière O; Sivadon-Tardy V; Coggia M; Gaillard JL
J Vasc Surg; 2007 Nov; 46(5):1026-31. PubMed ID: 17905555
[TBL] [Abstract][Full Text] [Related]
36. The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig.
Hernandez-Richter T; Schardey HM; Löhlein F; Heiss MM; Redondo-Müller M; Hammer C; Schildberg FW
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):413-8. PubMed ID: 11112458
[TBL] [Abstract][Full Text] [Related]
37. Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts.
Scharn DM; Oyen WJ; Klemm PL; Verhofstad AA; van der Vliet JA
J Surg Res; 2006 Aug; 134(2):182-9. PubMed ID: 16542682
[TBL] [Abstract][Full Text] [Related]
38. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system.
Chervu A; Moore WS; Gelabert HA; Colburn MD; Chvapil M
J Vasc Surg; 1991 Oct; 14(4):521-4; discussion 524-5. PubMed ID: 1833564
[TBL] [Abstract][Full Text] [Related]
39. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.
Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP
Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses.
Goëau-Brissonnière OA; Fabre D; Leflon-Guibout V; Di Centa I; Nicolas-Chanoine MH; Coggia M
J Vasc Surg; 2002 Jun; 35(6):1260-3. PubMed ID: 12042739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
